Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Kaveri S. Parker, James David Wilson, Jonas Marschall, Peter J. Mucha, Jeffrey P. Henderson
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation
10.1073/pnas.1000087107 · 2011
Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection
10.1128/iai.00319-08 · 2008
Multiresistant Gram-negative infections: a global perspective
10.1097/qco.0b013e32833f0d3e · 2010
Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections
10.7326/0003-4819-135-1-200107030-00012 · 2001
Urologic diseases in America Project: analytical methods and principal findings
10.1097/01.ju.0000152365.43125.3b · 2005
Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection
10.1128/aac.02176-12 · 2013
Antibiotics for emerging pathogens
10.1126/science.1176667 · 2009
Origins and virulence mechanisms of uropathogenic Escherichia coli
10.1016/j.yexmp.2008.03.007 · 2008
Bacterial iron sources: from siderophores to hemophores
10.1146/annurev.micro.58.030603.123811 · 2004
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%
Synthesis of chromone, quinolone, and benzoxazinone sulfonamide nucleosides as conformationally constrained inhibitors of adenylating enzymes required for siderophore biosynthesis
10.1021/jo400976f · 2013
Structural engineering of a phage lysin that targets Gram-negative pathogens
10.1073/pnas.1203472109 · 2012
Enterobactin-mediated delivery of beta-lactam antibiotics enhances antibacterial activity against pathogenic Escherichia coli
10.1021/ja503911p · 2014
Siderophore-drug complexes: potential medicinal applications of the “Trojan horse” strategy
10.1016/j.tips.2014.06.007 · 2014
Albomycin is an effective antibiotic, as exemplified with Yersinia enterocolitica and Streptococcus pneumoniae
10.1016/j.ijmm.2007.03.002 · 2007
Treatment and prevention of urinary tract infection with orally active FimH inhibitors
10.1126/scitranslmed.3003021 · 2011
Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection
10.1128/iai.00470-13 · 2013
Development of a recombinant FimCH vaccine for urinary tract infections
10.1007/978-1-4419-8889-8_41 · 2003
Targeting virulence: a new paradigm for antimicrobial therapy
10.1038/nchembio.2007.24 · 2007
From physiology to pharmacy: developments in the pathogenesis and treatment of recurrent urinary tract infections
10.1007/s11934-013-0354-5 · 2013
Both host and pathogen factors predispose to Escherichia coli urinary-source bacteremia in hospitalized patients
10.1093/cid/cis252 · 2012
Community detection in graphs
10.1016/j.physrep.2009.11.002 · 2010
Communities in networks
2009
Finding large average submatrices in high dimensional data
10.1214/09-aoas239 · 2009
Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis
10.1086/426450 · 2005
The siderophore yersiniabactin binds copper to protect pathogens during infection
10.1038/nchembio.1020 · 2012
Metal selectivity by the virulence-associated yersiniabactin metallophore system
10.1039/c4mt00341a · 2015
Human urinary composition controls siderocalin’s antibacterial activity
10.1074/jbc.m115.645812 · 2015
Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli
10.1371/journal.ppat.1000305 · 2009
Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine
10.1586/erv.12.36 · 2012
Global fluoroquinolone resistance epidemiology and implictions for clinical use
10.1155/2012/976273 · 2012
Similarity and divergence of phylogenies, antimicrobial susceptibilities, and virulence factor profiles of Escherichia coli isolates causing recurrent urinary tract infections that persist or result from reinfection
10.1128/jcm.02086-12 · 2012
Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance
10.1128/jcm.01488-07 · 2008
Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli
10.1093/jac/dki468 · 2006
Virulence characteristics and phylogenetic background of ciprofloxacin resistant Escherichia coli in the urine samples from Korean women with acute uncomplicated cystitis
10.3346/jkms.2010.25.4.602 · 2010
Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis
10.1128/aac.49.1.26-31.2005 · 2005
Virulence characteristics of Escherichia coli strains causing acute cystitis in young adults in Iran
10.1016/j.jinf.2004.05.021 · 2005
Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968 to 2012
10.1128/aac.03679-14 · 2014
Three-decade epidemiological analysis of Escherichia coli O15:K52:H1
10.1128/jcm.00230-09 · 2009
Prominence of an O75 clonal group (clonal complex 14) among non-ST131 fluoroquinolone-resistant Escherichia coli causing extraintestinal infections in humans and dogs in Australia
10.1128/aac.06120-11 · 2012
Molecular characterization of uropathogenic Escherichia coli: nalidixic acid and ciprofloxacin resistance, virulent factors and phylogenetic background
10.7860/jcdr/2013/6613.3744 · 2013
Biclustering algorithms for biological data analysis: a survey
10.1109/tcbb.2004.2 · doi-reference
Statistical mechanics of community detection
10.1103/physreve.74.016110 · doi-reference
Rapid and simple determination of the Escherichia coli phylogenetic group
10.1128/aem.66.10.4555-4558.2000 · doi-reference
Library on a slide for bacterial comparative genomics
10.1186/1471-2180-4-12 · doi-reference
Metabolomic analysis of siderophore cheater mutants reveals metabolic costs of expression in uropathogenic Escherichia coli
10.1021/pr4009749 · doi-reference
Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis
10.1111/j.1469-0691.2007.01775.x · doi-reference